Replenishing cartilage from endogenous stem cells

New England Journal of Medicine

Volumn 366, Issue 26, 2012, Pages 2522-2524

  Marini, Joan C ^a   Forlino, Antonella ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; CORE BINDING FACTOR BETA; FILAMIN A; GLYCOSAMINOGLYCAN; GROWTH PROMOTOR; KARTOGENIN; NITRIC OXIDE; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CELLULAR DISTRIBUTION; CHONDROGENESIS; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; HUMAN; INTRACELLULAR SIGNALING; KNEE LIGAMENT INJURY; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; OSTEOARTHRITIS; OSTEOGENESIS IMPERFECTA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGENERATIVE MEDICINE; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TISSUE SPECIFICITY;

EID: 84862864636     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr1204283     Document Type: Article

References (5)

1. Johnson K, Zhu S, Tremblay MS, et al. A stem cell-based approach to cartilage repair. Science 2012 April 5 (Epub ahead of print).
2. Hunter DJ. Pharmacologic therapy for osteoarthritis - the era of disease modification. Nat Rev Rheumatol 2011;7:13-22.
3. Yoshida N, Ogata T, Tanabe K, et al. Filamin A-bound PEBP2β/ CBFβ is retained in the cytoplasm and prevented from functioning as a partner of the Runx1 transcription factor. Mol Cell Biol 2005;25:1003-12. (Pubitemid 40165808)
4. Wurdak H, Zhu S, Min KH, et al. A small molecule accelerates neuronal differentiation in the adult rat. Proc Natl Acad Sci U S A 2010;107:16542-7.
5. Panaroni C, Gioia R, Lupi A, et al. In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 2009;114:459-68.